PPT Slide

• Its effectiveness compared to current therapies is small

• Its effectiveness hasn’t been convincingly demonstrated (lack of head-to-head comparisons, use of surrogate outcomes)

• Its price is much higher than the competitor, but its effectiveness isn’t

• It is only cost-effective in a subgroup of patients

There are four main reasons a drug doesn’t get listed as a general benefit:

Previous slide

Next slide

Back to first slide

View graphic version